Ornella Cantale

455 total citations
13 papers, 168 citations indexed

About

Ornella Cantale is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Ornella Cantale has authored 13 papers receiving a total of 168 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 7 papers in Pulmonary and Respiratory Medicine and 2 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Ornella Cantale's work include Cancer Immunotherapy and Biomarkers (6 papers), Lung Cancer Research Studies (5 papers) and Lung Cancer Treatments and Mutations (5 papers). Ornella Cantale is often cited by papers focused on Cancer Immunotherapy and Biomarkers (6 papers), Lung Cancer Research Studies (5 papers) and Lung Cancer Treatments and Mutations (5 papers). Ornella Cantale collaborates with scholars based in Italy, United Kingdom and Switzerland. Ornella Cantale's co-authors include Giuseppe Luigi Banna, Alfredo Addeo, Alex Friedlaender, Alessio Cortellini, Melissa Bersanelli, Marzia Del Re, Marco Banini, Alessandro De Toma, Domenico Galetta and Diego Signorelli and has published in prestigious journals such as European Journal of Cancer, The Oncologist and Frontiers in Oncology.

In The Last Decade

Ornella Cantale

13 papers receiving 168 citations

Peers

Ornella Cantale

ONCOL

PRM

RNMI

SURGE

IMMUN

Nick Pavlakis Australia

Wei‐Sen Lam Australia

Mathieu Baconnier France

Marco B. Polée Netherlands

Irene Pecora Italy

David Vicente Baz Spain

Светлана Проценко Russia

Shoni Philpot Australia

Xiao-Zhong Chen China

Fabiana Vitiello Italy

Nick Pavlakis Australia

Ornella Cantale

95 ×0.7

ONCOL

36 ×0.5

PRM

23 ×0.9

RNMI

22 ×1.1

SURGE

11 ×0.6

IMMUN

Citations per year, relative to Ornella Cantale Ornella Cantale (= 1×) peers Nick Pavlakis

Countries citing papers authored by Ornella Cantale

Since Specialization

Citations

This map shows the geographic impact of Ornella Cantale's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ornella Cantale with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ornella Cantale more than expected).

Fields of papers citing papers by Ornella Cantale

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ornella Cantale. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ornella Cantale. The network helps show where Ornella Cantale may publish in the future.

Co-authorship network of co-authors of Ornella Cantale

This figure shows the co-authorship network connecting the top 25 collaborators of Ornella Cantale. A scholar is included among the top collaborators of Ornella Cantale based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ornella Cantale. Ornella Cantale is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Longo, Vito, Domenico Galetta, Sara Pilotto, et al.. (2025). Correlation between irAEs and survival outcomes in patients with ES-SCLC treated with first-line chemoimmunotherapy. European Journal of Cancer. 221. 115435–115435. 2 indexed citations

Giannarelli, Diana, et al.. (2024). A cross-sectional study evaluating the exercise discussion with oncologist during cancer consultation: the CONNECT study. ESMO Open. 9(7). 103624–103624. 4 indexed citations

Bertaglia, Valentina, Simona Carnio, Ornella Cantale, et al.. (2024). Role of osimertinib plus brain radiotherapy versus osimertinib single therapy in EGFR-mutated non-small-cell lung cancer with brain metastases: A meta-analysis and systematic review. Critical Reviews in Oncology/Hematology. 205. 104540–104540. 5 indexed citations

Rizzo, Alessio, Ornella Cantale, L. Garetto, et al.. (2023). Assessing the role of colonic and other anatomical sites uptake by [¹⁸F]FDG‐PET/CT and immune‐inflammatory peripheral blood indexes in patients with advanced non‐small cell lung cancer treated with first‐line immune checkpoint inhibitors. Thoracic Cancer. 14(24). 2473–2483. 7 indexed citations

Cantale, Ornella, Veronica Mollica, Alfredo Addeo, et al.. (2023). First-line immunotherapy in non-small cell lung cancer: how to select and where to go. Expert Review of Respiratory Medicine. 17(12). 1191–1206. 4 indexed citations

Banna, Giuseppe Luigi, Ornella Cantale, Nicolò Matteo Luca Battisti, et al.. (2022). International Survey on Frailty Assessment in Patients with Cancer. The Oncologist. 27(10). e796–e803. 9 indexed citations

Banna, Giuseppe Luigi, Ornella Cantale, S. Muthuramalingam, et al.. (2022). Efficacy outcomes and prognostic factors from real-world patients with advanced non-small-cell lung cancer treated with first-line chemoimmunotherapy: The Spinnaker retrospective study. International Immunopharmacology. 110. 108985–108985. 21 indexed citations

Rundo, Francesco, Melissa Bersanelli, Alex Friedlaender, et al.. (2021). Three-Dimensional Deep Noninvasive Radiomics for the Prediction of Disease Control in Patients With Metastatic Urothelial Carcinoma treated With Immunotherapy. Clinical Genitourinary Cancer. 19(5). 396–404. 13 indexed citations

Cantale, Ornella, et al.. (2021). Role of the Combination of Cyclin-Dependent Kinase Inhibitors (CDKI) and Radiotherapy (RT) in the Treatment of Metastatic Breast Cancer (MBC): Advantages and Risks in Clinical Practice. Frontiers in Oncology. 11. 643155–643155. 18 indexed citations

10.

Caponnetto, S, Ornella Cantale, Alex Friedlaender, et al.. (2021). A Comparison Between First-, Second- and Third-Generation Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Patients with Non-Small-Cell Lung Cancer and Brain Metastases. IRIS Research product catalog (Sapienza University of Rome). 2(1). 1–10. 6 indexed citations

11.

Banna, Giuseppe Luigi, et al.. (2021). Risk of SARS-CoV2-Related Mortality in Non-Small Cell Lung Cancer Patients Treated with First-Line Immunotherapy Alone or in Combination with Chemotherapy. Cancer Investigation. 40(5). 406–412. 1 indexed citations

12.

Banna, Giuseppe Luigi, Diego Signorelli, Giulio Metro, et al.. (2020). Neutrophil-to-lymphocyte ratio in combination with PD-L1 or lactate dehydrogenase as biomarkers for high PD-L1 non-small cell lung cancer treated with first-line pembrolizumab. Translational Lung Cancer Research. 9(4). 1533–1542. 42 indexed citations

13.

Banna, Giuseppe Luigi, Ornella Cantale, Melissa Bersanelli, et al.. (2020). Are anti-PD1 and anti-PD-L1 alike? The non-small-cell lung cancer paradigm. Oncology Reviews. 14(2). 490–490. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact